Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll ...

A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to ...

Last week’s settlement that would see Purdue Pharma and its owners, the Sackler family, pay $7.4 billion to resolve lawsuits filed by state and local governments across the country is ...

A Williamsburg-based recovery advocate said she hopes the money will help local families and communities impacted by the crisis.

Last week’s settlement that would see Purdue Pharma and its owners, the Sackler family, pay $7.4 billion to resolve lawsuits filed by state and local governments across the country is ...

Purdue was instrumental in creating the US opioid crisis via aggressive marketing that did not reflect the true addiction ...

They've already stepped down from the company's board and have not taken distributions from Purdue since before ... family from civil lawsuits over OxyContin — even though the family members ...

The makers of Oxycontin have agreed to a $7.4 billion ... and the family’s company, Purdue Pharma, will pay nearly $900 million on court approval. Miyares accused Purdue of having a "leading ...

Last week, members of the Sackler family, which owns the pharmaceutical company known for selling OxyContin, agreed to a $7.4 ...

Pennsylvania looks likely to receive another big infusion of money from another court settlement over responsibility for the nation’s ongoing opioid epidemic. If the settlement is finalized, it will ...

The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...